Clinical Trials Directory

Trials / Completed

CompletedNCT05689268

EUS-PPG vs HVPG in Portal Hypertension

EUS-portal Pressure Gradient (EUS-PPG). Prospective Study Compared With Hepatic Venous Pressure Gradient (HVPG)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Hospital General Universitario de Alicante · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the correlation of the calculated portal pressure gradient (PPG) obtained by direct portal and hepatic pressure measurements with a conventional 22 G needle guided by EUS and indirect portal vein pressure measurements using the interventional radiology based hepatic venous pressure gradient (HVPG) procedure.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEUS-PPG and HVPGEUS-PPG and HVPG will be measured in all patients. Under deep sedation with propofol, an echoendoscopy will be performed. After identifying the left or middle suprahepatic vein, it will be punctured with a standard 22 G needle. The needle will be previously purged with heparinized saline and connected to a venous pressure monitor via an arterial pressure system, which will be calibrated to zero at the level of the axillary midline, at the level of the atrium. Subsequently, the left portal vein will be identified from the stomach or duodenum, repeating the procedure. From each vessel 3 measurements will be taken by flushing 1-2 ml of heparinized saline. The mean of the three measurements will be obtained. On the same day or on successive days HVPG measurement will be performed.

Timeline

Start date
2023-02-01
Primary completion
2023-09-20
Completion
2023-09-20
First posted
2023-01-19
Last updated
2023-09-21

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05689268. Inclusion in this directory is not an endorsement.